This inventor holds 1 USPTO granted patent. Top assignee: National Dong Hwa University. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Innovations in Cancer Treatment by Chia-Hung Lee
Introduction
Chia-Hung Lee is a notable inventor based in Hualien, Taiwan. He has made significant contributions to the field of cancer treatment through his innovative research and development. His work focuses on enhancing the efficacy of cancer therapies, which is crucial in the ongoing battle against this disease.
Latest Patents
Chia-Hung Lee holds a patent for an HCD formulation for cancer treatment. This novel formulation provides a method for enhancing the efficacy of HCD in treating cancer. Specifically, the invention involves copper-modified silica nanoparticles loaded with HCD, which demonstrate better efficacy than some conventional anticancer drugs. This advancement represents a promising step forward in cancer therapy.
Career Highlights
Chia-Hung Lee is affiliated with National Dong Hwa University, where he conducts his research and development activities. His academic background and ongoing research contribute to the advancement of medical science, particularly in oncology.
Collaborations
Chia-Hung Lee collaborates with esteemed colleagues, including Ching-Feng Weng and Yi-Chen Chia. These partnerships enhance the research efforts and foster innovation in cancer treatment methodologies.
Conclusion
Chia-Hung Lee's contributions to cancer treatment through his innovative HCD formulation highlight the importance of research in developing effective therapies. His work not only showcases his expertise but also offers hope for improved cancer treatment options in the future.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile